home / stock / qure / qure news

QURE News and Press, uniQure N.V.

Stock Information
Company Name: uniQure N.V.
Stock Symbol: QURE
Market: NASDAQ
Website: uniqure.com
Menu
QURE QURE Quote QURE Short QURE News QURE Articles QURE Message Board
Get QURE Alerts

News, Short Squeeze, Breakout and More Instantly...
QURE - uniQure used 'distorted comparison' in Huntington's asset trial: FDA official

2026-03-05 19:27:49 ET More on uniQure uniQure: Worst Case Scenario Becomes Reality uniQure: The Worst Case Scenario Just Got Official (Rating Downgrade) uniQure N.V. (QURE) Q4 2025 Earnings Call Transcript uniQure plummets as FDA calls for phase 3 trial for ...
QURE - uniQure: Worst Case Scenario Becomes Reality

2026-03-03 22:22:59 ET uniQure's ( QURE ) stock plummeted again on Monday after the company announced that it did not make any progress in its Type A meeting with the FDA about its AMT-130 Huntington's disease treatment. If anything, the FDA's position appears to have hardened consi...

QURE - HQH: Strong Returns Fuel Higher Payout, But Valuation Not As Compelling (Downgrade)

2026-03-03 17:28:08 ET Written by Nick Ackerman, co-produced by Stanford Chemist We had noted in our prior update on abrdn Healthcare Investors ( HQH ) that the fund was starting to do well. This was after healthcare started to get some more love from investors, after be...

QURE - US Companies Moving the Markets, Morning edition
Tue, Mar 03, 2026 as of 10.00 am ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.0% to $1.79 on volume of 996,349,655 shares Trio Petroleum Corp. (TPET) rose 166.7% to $1.12 on volume of 438,512,550 shares NVIDIA Corporation (NVDA) rose 3.0% to $182.48 on vol...
QURE - uniQure: The Worst Case Scenario Just Got Official (Rating Downgrade)

2026-03-03 08:15:20 ET uniQure Overview My last analysis of uniQure N.V. ( QURE ) followed a setback for its Huntington’s gene therapy, AMT-130. In an apparent reversal, the FDA reportedly no longer endorsed uniQure’s Phase 1/2 data—which featured a natu...

QURE - Market Perform Recommendation Issued On QURE By Bernstein

2026-03-03 07:15:02 ET Bernstein analyst issues MARKET PERFORM recommendation for QURE on March 3, 2026 11:31AM ET. QURE was trading at $10.5 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Strong Buy...

QURE - uniQure plummets as FDA calls for phase 3 trial for Huntington's asset AMT-130

2026-03-02 16:59:18 ET More on uniQure uniQure N.V. (QURE) Q4 2025 Earnings Call Transcript uniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should Know uniQure: Now What? UniQure outlines next steps for Huntington’s program as FDA reco...
QURE - UniQure outlines next steps for Huntington's program as FDA recommends Phase III sham-controlled trial

2026-03-02 16:28:38 ET More on uniQure uniQure N.V. (QURE) Q4 2025 Earnings Call Transcript uniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should Know uniQure: Now What? uniQure falls after FDA commissioner’s comments on rare disease ...

QURE - uniQure N.V. (QURE) Q4 2025 Earnings Call Transcript

2026-03-02 16:27:50 ET uniQure N.V. (QURE) Q4 2025 Earnings Call March 2, 2026 8:00 AM EST Company Participants Chiara Russo - Senior Director of Investor Relations Matthew Kapusta - CEO & Executive Director Walid Abi-Saab - Chief Medical Officer Kylie O'...

QURE - US Companies Moving the Markets, Evening edition
Mon, Mar 02, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 2.2% to $1.83 on volume of 883,419,339 shares Trio Petroleum Corp. (TPET) rose 157.5% to $1.0816 on volume of 411,497,833 shares Ondas Inc (ONDS) rose 2.6% to $10.34 on volume of 1...
Next 10